An observational study for identifying blood biomarkers associated with clinical benefit from carboplatin and pemetrexed (CbP) treatment in patients with non-squamous (NS) non-small cell lung cancer (NSCLC) (CJLSG1201)
An observational study for identifying blood biomarkers associated with clinical benefit from carboplatin and pemetrexed (CbP) treatment in patients with non-squamous (NS) non-small cell lung cancer (NSCLC) (CJLSG1201)
复制标题
一项观察性研究，旨在确定与卡铂和培美曲塞 (CbP) 治疗非鳞状 (NS) 非小细胞肺癌 (NSCLC) 患者临床获益相关的血液生物标志物 (CJLSG1201)
DOI：
--
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
Mas
中科院分区：
文献类型：
--
作者：
Tetsunari Hase;Kiyoshi Yanagisawa;Asuki Fukatsu;Tomoki Kimura;Eiji Kojima;Takashi Abe;Kazuyoshi Imaizumi;Yoshitsugu Horio;Tetsuya Oguri;Masashi Yamamoto;Tomohiko Ogasawara;Yasuteru Sugino;Masahiro Morise;Masahiro Nakatochi;Masahiko Ando;Mas
